Navigation Links
Telik Announces Financial Results for 2008 Third Quarter
Date:11/5/2008

ug candidates in clinical development are TELINTRA(R), a modified glutathione analog for the treatment of cytopenias due to myelodysplastic syndrome or chemotherapy, and TELCYTA(R), a tumor-activated prodrug for the treatment of advanced ovarian cancer and non-small cell lung cancer. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates.

This press release contains "forward-looking" statements, including statements regarding Telik's future development of TELINTRA and TELCYTA. These forward-looking statements are based upon Telik's current expectations. There are important factors that could cause Telik's results to differ materially from those indicated by these forward-looking statements, including, among others, if clinical trials of TELINTRA or TELCYTA are delayed or unsuccessful, Telik's business would suffer, if Telik's competitors develop and market products that are more effective than its product candidates or any product that Telik may develop, or obtain marketing approval before Telik does, Telik's commercial opportunity will be reduced or eliminated, and if Telik does not obtain regulatory approval to market products in the U.S. and foreign countries, Telik will not be permitted to commercialize its product candidates. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release may be found in Telik's periodic filings with the Securities and Exchange Commission, including the factors described in the section entitled "Risk Factors" in its quarterly report on Form 10-Q for the quarter ended June 30, 2008. Telik does not undertake any obligation to update forward-looking statements contained in this press release.

TELIK, the Telik logo, TELINTRA, TELCYTA and TRAP are trademarks or registered trademarks of Telik, In
'/>"/>

SOURCE Telik, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer
2. Telik Announces 2008 Third Quarter Financial Release, Conference Call and Webcast
3. Telik Announces Receipt of Nasdaq Notice
4. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
5. ReceptorBio Announces Diabetes License Agreement With Telik
6. Telik Announces Financial Results For 2008 Second Quarter
7. Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast
8. Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters
9. Telik Announces Presentation and Webcast at Needham Biotechnology Conference
10. Telik Announces First Quarter 2008 Financial Results
11. Telik Presents Preclinical Data at 99th Annual Meeting of the American Association for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Automated cell culture systems are instruments that mechanically ... allow production of optimum cells at a large scale ... and industries and biopharmaceutical companies. Cell culture automation systems ... cell-based assays, and cellular expression systems as they save ... Global Cell Culture market will grow at ...
(Date:7/22/2014)...  Neogen Corporation (NASDAQ: NEOG ) announced ... ended May 31, increased 19% from the previous year ... to the prior year,s $27,190,000. Adjusted for a 3-for-2 ... in the current year were $0.76, compared to $0.75 ... the 2014 fiscal year established new all-time highs for ...
(Date:7/22/2014)... , July 22, 2014 Hussey ... of MD-Cu 29 antimicrobial copper announces Pullman Regional ... the first EPA-registered antimicrobial solid touch surface, at a ... 99.9% of MRSA, E-coli and other bacteria within 2 hours ... in protecting against bacteria and infectious diseases in its ...
(Date:7/22/2014)... July 22, 2014  United Therapeutics Corporation (NASDAQ: ... will release its second quarter 2014 financial results ... United Therapeutics will host a half-hour ... a.m. Eastern Time.  The teleconference is accessible by ... rebroadcast of the teleconference will be available for ...
Breaking Biology Technology:Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 2Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 3Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 4Neogen reports 19% increase in annual revenues 2Neogen reports 19% increase in annual revenues 3Neogen reports 19% increase in annual revenues 4Neogen reports 19% increase in annual revenues 5Neogen reports 19% increase in annual revenues 6Neogen reports 19% increase in annual revenues 7Neogen reports 19% increase in annual revenues 8Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 2Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 3
... In trying to explain the complexities of the biotech industry ... that it is a long, painstaking and expensive process. What they ... drug discovery and development process shows us the following pathway: ... , , If the patent life of a drug is ...
... Brian Howell, who elevated technology and business coverage at ... lung cancer. He was 53. , ,Before becoming ... was features editor and, previously, national-foreign editor of the ... included reporting and editing stints in Montana, Minnesota and ...
... lot of talk about customers. Calling on customers. Securing ... many years of loose talk about brand building that ... the brand reputation as much as the vendor does. ... two incredible software companies, customers never really went out ...
Cached Biology Technology:The Complexities, Cost of Midwest Biotech Drug Development 2The Complexities, Cost of Midwest Biotech Drug Development 3The Complexities, Cost of Midwest Biotech Drug Development 4Madison Magazine Editor Dies of Lung Cancer 2The Secret of Success: Listen To Customers 2The Secret of Success: Listen To Customers 3
(Date:7/21/2014)... conserve water and save on your utility bill? A ... in the current issue of the journal Environment ... Most Effective Actions U.S. Households Can Take to Curb ... substantially by simple actions such as installing more efficient ... the suggestions may be familiar, the researchers are the ...
(Date:7/21/2014)... 21, 2014 Dysfunction in dopamine signaling profoundly ... in the brain,s prefrontal cortex and may be ... such as schizophrenia, according to UC Irvine scientists. ... brain cells that receive this neurotransmitter showed for ... a variety of behavioral and physiological functions regulated ...
(Date:7/21/2014)... A team of University of California, Riverside Bourns College of ... the grates of a backyard grill reduces by 70 percent ... The one-eighth inch thick steel carbon plate with an insulated ... a slit into the grill to allow the plate to ... by grill manufacturers who could sell new grills with the ...
Breaking Biology News(10 mins):Researchers provide guide to household water conservation 2Researchers provide guide to household water conservation 3UCI researchers find epigenetic tie to neuropsychiatric disorders 2Catching grease to cut grill pollution 2
... Conn. Triceratops and Torosaurus have long been ... discovery traces the giants, family tree further back in time, ... before its more well-known descendants, making it the earliest known ... Titanoceratops after the Greek myth of the Titans, ...
... brightly glowing nanoparticles may soon be used to light ... U.S. Food and Drug Administration (FDA) has approved the first clinical ... time the FDA has approved using an inorganic material in the ... finally puts a federal approval stamp on all the assumptions we ...
... in genes requires cells to process "messenger RNA" molecules before ... It was long believed that this was simply part ... new types of protein but recent work has made it ... And so attention is gradually shifting to asking why ...
Cached Biology News:Newly discovered dinosaur likely father of Triceratops 2'Cornell Dots' that light up cancer cells go into clinical trials 2If junk DNA is useful, why is it not shared more equally? 2
GOAT ANTI PPP2R5B...
... Molecular Probes Fc OxyBURST Green reagent ... Simons of Boston University to permit measurement ... internalization and the subsequent oxidative burst directly ... assay reagent consists of bovine serum albumin ...
anti-dansyl, rabbit IgG fraction *1 mg/mL* Secondary Detection; Anti-Dye and Anti-Hapten Antibodies...
MOUSE ANTI RAT RT1Bu / MOUSE Ia:BIOTIN Immunogen: Rat thymocyte membrane glycoproteins...
Biology Products: